Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 60,653,808
- Total 13F value
- $448,777,384
- Share change
- -106,060
- Put/Call ratio
- 57%
- SEC-reported price per share
- $7.40
- Number of holders
- 111
- Value change
- -$37,107,153
- Number of buys
- 68
- Number of sells
- 44
- Shares outstanding
- 51,428,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
111
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 21%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 21%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
21%
BAUPOST GROUP LLC/MA
19%
WELLINGTON MANAGEMENT GROUP LLP
17%
VANGUARD GROUP INC
10%
ORBIMED ADVISORS LLC
8.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
21%
|
$156,698,000
10,791,863 shares
|
— | 30 Jun 2021 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
19%
|
$143,896,000
9,910,168 shares
|
— | 30 Jun 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
17%
|
$126,720,000
8,727,324 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$76,651,000
5,278,969 shares
|
— | 30 Jun 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
8.9%
|
$66,270,000
4,564,045 shares
|
— | 30 Jun 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
8.8%
|
$65,640,000
4,520,707 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
60,653,808
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
101
Q3 2021 holders
111
Holder diff
10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend